EVERSANA operates in the life sciences sector, providing integrated commercial services to pharmaceutical companies of all sizes. The company addresses critical challenges in drug pricing, access, reimbursement, adherence, and product delivery. EVERSANA serves a diverse range of clients, including large pharmaceutical firms and smaller biotech companies, offering a comprehensive suite of services that span the entire product lifecycle. The business model is service-based, generating revenue through consulting, market access strategies, patient services, and field deployment solutions. EVERSANA's global footprint includes more than 30 locations, enabling it to deliver tailored solutions to clients worldwide. The company is recognized for its industry-leading services and has earned numerous accreditations and awards.

Keywords: life sciences, pharmaceutical, drug pricing, market access, reimbursement, adherence, product delivery, consulting, patient services, global footprint.